Literature DB >> 3828655

An in vitro analysis of purine-mediated renal vasoconstriction in rat isolated kidney.

T P Kenakin, N B Pike.   

Abstract

In the rat isolated perfused kidney, 2-chloroadenosine and L-N6-phenyl-isopropyl adenosine (L-PIA) produced a modest vasodilatation. After kidneys had been pretreated with methoxamine (to elevate vascular tone) and forskolin (to activate adenyl cyclase and reduce vascular tone), both purine agonists produced vasoconstriction at low doses and vasodilatation at higher doses. This was consistent with the working hypothesis that vasoconstriction resulted from activation of A1-purinoceptors mediating adenyl cyclase inhibition and vasodilatation from activation of A2-purinoceptors stimulating adenyl cyclase. These kidney preparations also demonstrated a marked potentiation of purine-mediated vasoconstriction in the presence of various concentrations of 8-p-sulpho-phenyltheophylline (8-SPT), a drug reported in the literature to be a competitive antagonist of A1- and A2-purinoceptors. Maximal renal vasoconstriction to 2-chloroadenosine and L-PIA was observed in the presence of 10 mM 8-SPT; the fact that this vasoconstriction was sensitive to the selective A1-receptor antagonist 8-(2-amino-4-chlorophenyl)-1,3-dipropylxanthine (PACPX) and that the order of potency of agonists for this effect was L-PIA greater than 2-chloroadenosine greater than D-PIA greater than N6-ethylcarboxamide adenosine (NECA) was consistent with activation of vascular A1-purinoceptors. While these data are consistent with the hypothesis that purines activate vascular A1- and A2-receptors in the rat isolated kidney, the nature of the results did not allow definitive classification of the receptors mediating the purine effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828655      PMCID: PMC1916936          DOI: 10.1111/j.1476-5381.1987.tb08967.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Renal effects of adenosine and their inhibition by theophylline in dogs.

Authors:  H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

3.  Adenosine response of the rat kidney after saline loading, sodium restriction and hemorrhagia.

Authors:  H Osswald; H J Schmitz; O Heidenreich
Journal:  Pflugers Arch       Date:  1975-06-26       Impact factor: 3.657

4.  Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney.

Authors:  P Hedqvist; B B Fredholm; S Olundh
Journal:  Circ Res       Date:  1978-10       Impact factor: 17.367

5.  Effects of adenosine compounds on renal function and renin secretion in dogs.

Authors:  H Tagawa; A J Vander
Journal:  Circ Res       Date:  1970-03       Impact factor: 17.367

6.  Metabolically linked vasoactive chemicals in local regulation of blood flow.

Authors:  F J Haddy; J B Scott
Journal:  Physiol Rev       Date:  1968-10       Impact factor: 37.312

7.  Renal action of adenosine: effect on renin secretion in the rat.

Authors:  H Osswald; H J Schmitz; R Kemper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

8.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

Review 9.  Pathogenesis of acute noninflammatory renal failure.

Authors:  H Börner; H Klinkmann
Journal:  Nephron       Date:  1980       Impact factor: 2.847

10.  Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine.

Authors:  R F Bruns; J W Daly; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

View more
  7 in total

1.  Characterization of the P1-purinoceptors mediating contraction of the rat colon muscularis mucosae.

Authors:  S J Bailey; D Hickman; S M Hourani
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

2.  Subtypes of purinoceptors in rat and dog urinary bladder smooth muscles.

Authors:  H Suzuki; S Kokubun
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

3.  Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs.

Authors:  A J Szentmiklósi; A Ujfalusi; A Cseppentö; K Nosztray; P Kovács; J Z Szabó
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

4.  Contraction of the rat isolated spleen mediated by adenosine A1 receptor activation.

Authors:  J R Fozard; M Milavec-Krizman
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Vascular actions of purines in the foetal circulation of the human placenta.

Authors:  M A Read; A L Boura; W A Walters
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Direct effects of adenylyl 5'-(beta,gamma-methylene)diphosphonate, a stable ATP analogue, on relaxant P1-purinoceptors in smooth muscle.

Authors:  S M Hourani; S J Bailey; J Nicholls; I Kitchen
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

7.  Effects of purines on the longitudinal muscle of the rat colon.

Authors:  S J Bailey; S M Hourani
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.